These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33461863)

  • 1. 1,25-dihydroxyvitamin D3 induces stable and reproducible therapeutic tolerogenic dendritic cells with specific epigenetic modifications.
    van Megen KM; Chen Z; Joosten AM; Laban S; Zwaginga JJ; Natarajan R; Nikolic T; Roep BO
    Cytotherapy; 2021 Mar; 23(3):242-255. PubMed ID: 33461863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential transcriptome of tolerogenic versus inflammatory dendritic cells points to modulated T1D genetic risk and enriched immune regulation.
    Nikolic T; Woittiez NJC; van der Slik A; Laban S; Joosten A; Gysemans C; Mathieu C; Zwaginga JJ; Koeleman B; Roep BO
    Genes Immun; 2017 Sep; 18(3):176-183. PubMed ID: 28794505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis.
    Harry RA; Anderson AE; Isaacs JD; Hilkens CM
    Ann Rheum Dis; 2010 Nov; 69(11):2042-50. PubMed ID: 20551157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells.
    Dáňová K; Grohová A; Strnadová P; Funda DP; Šumník Z; Lebl J; Cinek O; Průhová Š; Koloušková S; Obermannová B; Petruželková L; Šedivá A; Fundová P; Buschard K; Špíšek R; Palová-Jelínková L
    J Immunol; 2017 Jan; 198(2):729-740. PubMed ID: 27927966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
    Funda DP; Goliáš J; Hudcovic T; Kozáková H; Špíšek R; Palová-Jelínková L
    Front Immunol; 2018; 9():290. PubMed ID: 29503651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous tolerogenic dendritic cells derived from monocytes of systemic lupus erythematosus patients and healthy donors show a stable and immunosuppressive phenotype.
    Obreque J; Vega F; Torres A; Cuitino L; Mackern-Oberti JP; Viviani P; Kalergis A; Llanos C
    Immunology; 2017 Dec; 152(4):648-659. PubMed ID: 28763099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyburide-treated human monocyte-derived dendritic cells loaded with insulin represent tolerogenic features with anti-inflammatory responses and modulate autologous T cell responses in vitro.
    Alipour S; Kazemi T; Sadeghi MR; Heris JA; Masoumi J; Naseri B; Baghbani E; Sohrabi S; Baradaran B
    Int Immunopharmacol; 2024 Jan; 126():111230. PubMed ID: 37979448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines.
    García-González P; Morales R; Hoyos L; Maggi J; Campos J; Pesce B; Gárate D; Larrondo M; González R; Soto L; Ramos V; Tobar P; Molina MC; Pino-Lagos K; Catalán D; Aguillón JC
    J Transl Med; 2013 May; 11():128. PubMed ID: 23706017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?
    Funda DP; Palová-Jelínková L; Goliáš J; Kroulíková Z; Fajstová A; Hudcovic T; Špíšek R
    Front Immunol; 2019; 10():967. PubMed ID: 31139178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matured Tolerogenic Dendritic Cells Effectively Inhibit Autoantigen Specific CD4
    Jansen MAA; Spiering R; Ludwig IS; van Eden W; Hilkens CMU; Broere F
    Front Immunol; 2019; 10():2068. PubMed ID: 31555285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Tolerogenic Features on Dexamethasone-Modulated MPLA-Activated Dendritic Cells by MYC.
    García-González PA; Maggi J; Schinnerling K; Sepúlveda-Gutiérrez A; Soto L; Neira O; Mehdi AM; Nel HJ; Pesce B; Aravena O; Molina MC; Catalán D; Thomas R; Verdugo RA; Aguillón JC
    Front Immunol; 2019; 10():1171. PubMed ID: 31191540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidimensional analyses of proinsulin peptide-specific regulatory T cells induced by tolerogenic dendritic cells.
    Suwandi JS; Laban S; Vass K; Joosten A; van Unen V; Lelieveldt BPF; Höllt T; Zwaginga JJ; Nikolic T; Roep BO
    J Autoimmun; 2020 Feb; 107():102361. PubMed ID: 31776056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members.
    Dixon KO; van der Kooij SW; Vignali DA; van Kooten C
    Eur J Immunol; 2015 Jun; 45(6):1736-47. PubMed ID: 25820702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of tolerogenic dendritic cells using dexamethasone and 1,25-dihydroxyvitamin D3 represses autologous T cell activation and chondrocyte inflammation.
    Wang G; Zhang J; Fang Y; Cao W; Xu B; Chen X
    Exp Ther Med; 2019 Jan; 17(1):679-688. PubMed ID: 30651850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GENERATION OF TOLEROGENIC DENDRITIC CELLS UNDER THE PERSISTENT INFLAMMATION STIMULATION.
    Miao S; Chang Z; Gu B; Jiang J; Pei F; Liu Y; Zhou Y; Liu Z; Si X; Guan X; Wu J
    Shock; 2024 Mar; 61(3):454-464. PubMed ID: 38412105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent discoveries in dendritic cell tolerance-inducing pharmacological molecules.
    Švajger U; Rožman PJ
    Int Immunopharmacol; 2020 Apr; 81():106275. PubMed ID: 32044665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis.
    Schinnerling K; Soto L; García-González P; Catalán D; Aguillón JC
    Autoimmun Rev; 2015 Jun; 14(6):517-27. PubMed ID: 25633325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening identification of novel immunomodulatory combinations for the generation of tolerogenic dendritic cells.
    Jia S; Kim J; Esser-Kahn AP; Deak P
    Front Med (Lausanne); 2023; 10():1298424. PubMed ID: 38249971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of tolerogenic dendritic cells towards heat-shock proteins: a novel therapeutic strategy for autoimmune diseases?
    Jansen MAA; Spiering R; Broere F; van Laar JM; Isaacs JD; van Eden W; Hilkens CMU
    Immunology; 2018 Jan; 153(1):51-59. PubMed ID: 28804903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific tolerogenic dendritic cells ameliorate the severity of murine collagen-induced arthritis.
    Ning B; Wei J; Zhang A; Gong W; Fu J; Jia T; Yang SY
    PLoS One; 2015; 10(6):e0131152. PubMed ID: 26107250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.